BI 1323495
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for BI 1323495, covering 2024-02-22 to 2024-11-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation [Phase 1]